Tourniquet (junctional): Difference between revisions
(Created page with "==Background== * Junctional Tourniquets (JTQ) were initially cleared by FDA in 2010 for use in pre-hospital medicine * JTQs were developed because of limitations of traditiona...") |
(Minor change to correct inappropriate capitialization) |
||
| Line 52: | Line 52: | ||
# Kotwal, R.S., et al. Management of Junctional Hemorrhage in Tactical Combat Casualty Care: TCCC Guidelines-Proposed Change 13-03. J Spec Oper Med, 2013. 13(4): 85-93. | # Kotwal, R.S., et al. Management of Junctional Hemorrhage in Tactical Combat Casualty Care: TCCC Guidelines-Proposed Change 13-03. J Spec Oper Med, 2013. 13(4): 85-93. | ||
[[Category: | [[Category:Military]] | ||
Revision as of 17:51, 19 January 2018
Background
- Junctional Tourniquets (JTQ) were initially cleared by FDA in 2010 for use in pre-hospital medicine
- JTQs were developed because of limitations of traditional extremity tourniquets in controlling hemorrhage between the trunk and limbs. These difficult to access locations were responsible for 20% of preventable deaths by bleeding on the battlefield.
- JTQs are devices that allow for proximal compression of arterial bleeding and thus control of junctional hemorrhage.
- Lethality of junctional hemorrhage is greater because of the large lumen size of injured vessels
Desirable Traits of a JTQ
- Stop bleeding effectively from junction areas such as groin, pelvis, buttock, shoulder, or neck
- Compress bleeding from sites where regular TQ cannot be applied
- Safe to use
- Effective for prehospital use
- Small with low profile
- Lightweight
- Low-cost
- Easy to use requiring minimal training
- Applied quickly
- Does not slip on tightening when in use
- Provides easy release of compression
- Easy to reapply
- Long shelf life
Indications
- Junctional hemorrhage not controlled by pressure dressing
- Some JTQ can also be used to stabilize suspected pelvic fractures
- Testing has shown JTQ to be 75-100% effect in controlling hemorrhage
Contraindications
- Not applicable
- N.B. there is on the market a truncal tourniquet which has been cleared by the FDA for junctional hemorrhage. This device is contraindicated in pregnancy, abdominal aortic aneurysm, and penetrating abdominal trauma.
Application of Tourniquet
- As per manufacturer's guidance
- Committee on Tactical Combat Casualty Care lists three possible devices
Precautions
- Do not remove JTQ which has been in place more than 6 hours
- Expose and clearly mark all tourniquets with time of application
Proper Removal
- ASAP convert junctional tourniquet to hemostatic pressure dressing if:
- Patient not in shock
- It is possible to monitor the wound closely for bleeding
- JTQ is not being used to control bleeding form an amputated extremity or to stabilize a suspected pelvic fracture
- If bleeding recurs after removal in hospital consider non-surgical interventions such as direct pelvic packing, vessel ligation, Foley or extravascular balloon tamponade although specific technique will depend on resources and skills available
References
- Kragh, J.F., Jr., et al., Testing of junctional tourniquets by military medics to control simulated groin hemorrhage. J Spec Oper Med, 2014. 14(3): p. 58-63.
- Klotz, J.K., et al., First case report of SAM(r) Junctional tourniquet use in Afghanistan to control inguinal hemorrhage on the battlefield. J Spec Oper Med, 2014. 14(2): p. 1-5.
- Kragh, J.F., et al., Assessment of Groin Application of Junctional Tourniquets in a Manikin Model. Prehosp Disaster Med, 2016. 31(4): p. 358-63.
- Kotwal, R.S., et al. Management of Junctional Hemorrhage in Tactical Combat Casualty Care: TCCC Guidelines-Proposed Change 13-03. J Spec Oper Med, 2013. 13(4): 85-93.
